COVID-19: New Emergency Guidance From AAMI Targets Remote-Controlled Devices
Executive Summary
Consensus report CR511 from the Association for the Advancement of Medical Instrumentation highlights common system elements for engineers, and outlines safety and risk-control measures that manufacturers and caregivers should consider.
You may also be interested in...
COVID-19: FDA Expands List Of Remote Monitoring Devices That Don’t Need Premarket Notification
The US agency has added gaseous-phase carbon-dioxide gas analyzers to its list of products that – during the coronavirus pandemic – will not require a new premarket notification to be marketed for remote monitoring.
Device Week, 14 January 2021 – FDA Commissioner News; Spotlight On COVID-19 Enforcement Issues
On this week’s podcast we talk about outgoing US FDA chief Stephen Hahn and the role he wants to play beyond 20 January, as an ex-commissioner. We also discuss the US enforcement landscape around COVID-19-related products and how it’s still taking shape.
FDA Issues 5-Point Action Plan For Artificial Intelligence/Machine Learning-Based SaMD
A new guidance document and a promise to hold a public workshop are just two commitments made by the US agency in a 12 January action plan aimed at AI/ML-based software as a medical device.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: